Ryan Fukushima
Chief Executive Officer chez RAIN ONCOLOGY INC.
Profil
Ryan Fukushima is the founder of Pathos AI, Inc. (founded in 2021), and currently serves as the Chief Executive Officer of Rain Oncology, Inc. and as the Chief Operating Officer of Tempus Labs, Inc. He previously worked as a Principal at Michigan Ross Zell Lurie Institute, Tapjoy, Inc., and as an Associate at TechStars Central, LLC, Huron River Venture Partners LLC, and Hyde Park Venture Partners Management LLC.
He also served as the Vice President at Lightbank LLC from 2014 to 2016.
Mr. Fukushima holds an MBA from the University of Michigan and a graduate degree from the same institution.
He also holds an undergraduate degree from California Polytechnic State University (San Luis Obispo) and an MBA from the Stephen M.
Ross School of Business.
Postes actifs de Ryan Fukushima
| Sociétés | Poste | Début |
|---|---|---|
| RAIN ONCOLOGY INC. | Chief Executive Officer | - |
Tempus Labs, Inc.
 Tempus Labs, Inc. Information Technology ServicesTechnology Services Tempus Labs, Inc. enagegs in the development of a platform that analyzes clinical and molecular data points focusing on cancer research. It connects physicians treatment options and relevant insights for patients based on their unique molecular profile and analytics and machine-learning algorithms. The firm offers genomic sequencing, clinical data structuring, image recognition, biological modeling, and time trial program. The company was founded by Bradley A. Keywell and Eric P. Lefkofsky in 2015 and is headquartered in Chicago, IL. | Chief Operating Officer | 01/01/2015 |
Pathos AI, Inc.
 Pathos AI, Inc. BiotechnologyHealth Technology The American company was founded by Ryan Fukushima and Eric Paul Lefkofsky, with Ryan Fukushima serving as the CEO since incorporation. Pathos AI leverages the power of AI technologies, multimodal real-world data, and patient-derived biological models to bring precision medicines to market through partnerships with biopharmaceutical companies. The company is focused on re-engineering drug development with the power of advanced AI technologies and has built a proprietary platform and operating model called Pathos to gain crucial insights and act on them at scale. | Founder | - |
Anciens postes connus de Ryan Fukushima
| Sociétés | Poste | Fin |
|---|---|---|
Lightbank LLC
 Lightbank LLC Investment ManagersFinance Lightbank LLC (Lightbank) is a venture capital firm founded in 2010 by Eric Paul Lefkofsky and Bradley A. Keywell. The firm is headquartered in Chicago, Illinois. | Private Equity Investor | 31/12/2016 |
Hyde Park Venture Partners Management LLC
 Hyde Park Venture Partners Management LLC Investment ManagersFinance Hyde Park Venture Partners Management LLC (Hyde Park Venture Partners) is a venture capital firm founded in 2011 by Guy Turner. The firm is headquartered in Chicago, Illinois. | Corporate Officer/Principal | 01/02/2014 |
Michigan Ross Zell Lurie Institute / Venture Capital/
 Michigan Ross Zell Lurie Institute / Venture Capital/ Investment ManagersFinance Michigan Ross Zell Lurie Institute / Venture Capital/ (Zell Lurie Institute) is a venture capital subsidiary of Zell Lurie Institute for Entrepreneurial Studies Studies founded in 1997 by Samuel Zell, Ann Lurie and Robert H. Lurie. The firm is headquartered in Ann Arbor, Michigan. | Corporate Officer/Principal | - |
Huron River Venture Partners LLC
 Huron River Venture Partners LLC Investment ManagersFinance Huron River Venture Partners LLC (Huron River Venture) is a venture capital firm founded in 2010 by Ryan Waddington and Tim Streit. The firm is headquartered in Ann Arbor, Michigan. | Corporate Officer/Principal | - |
Tapjoy, Inc.
 Tapjoy, Inc. Packaged SoftwareTechnology Services Tapjoy, Inc. provides social and mobile applications. The firm operates as a mobile performance-based advertising platform that drives deep engagement and monetization opportunities for app publishers, while delivering valuable, engaged consumers to some of the brand advertisers. It has locations in Atlanta, Beijing, Boston, Chicago, London, Los Angeles, New York, Santa Barbara, San Francisco, Seoul, Shanghai and Tokyo. The company was founded by Ben Lewis, Shukla Anu, Lee Linden and Mitch Liu in 2007 and is headquartered San Francisco, CA. | Corporate Officer/Principal | - |
Formation de Ryan Fukushima
| University of Michigan | Masters Business Admin |
| California Polytechnic State University (San Luis Obispo) | Undergraduate Degree |
| Stephen M. Ross School of Business | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 9 |
|---|---|
Michigan Ross Zell Lurie Institute / Venture Capital/
Michigan Ross Zell Lurie Institute / Venture Capital/ Investment ManagersFinance Michigan Ross Zell Lurie Institute / Venture Capital/ (Zell Lurie Institute) is a venture capital subsidiary of Zell Lurie Institute for Entrepreneurial Studies Studies founded in 1997 by Samuel Zell, Ann Lurie and Robert H. Lurie. The firm is headquartered in Ann Arbor, Michigan. | Finance |
TechStars Central, LLC
 TechStars Central, LLC Investment ManagersFinance TechStars Central LLC (TechStars) is an Independent Accelerator Incubator firm founded in 2006. The firm is headquartered in the US.. | Finance |
Tapjoy, Inc.
Tapjoy, Inc. Packaged SoftwareTechnology Services Tapjoy, Inc. provides social and mobile applications. The firm operates as a mobile performance-based advertising platform that drives deep engagement and monetization opportunities for app publishers, while delivering valuable, engaged consumers to some of the brand advertisers. It has locations in Atlanta, Beijing, Boston, Chicago, London, Los Angeles, New York, Santa Barbara, San Francisco, Seoul, Shanghai and Tokyo. The company was founded by Ben Lewis, Shukla Anu, Lee Linden and Mitch Liu in 2007 and is headquartered San Francisco, CA. | Technology Services |
Lightbank LLC
Lightbank LLC Investment ManagersFinance Lightbank LLC (Lightbank) is a venture capital firm founded in 2010 by Eric Paul Lefkofsky and Bradley A. Keywell. The firm is headquartered in Chicago, Illinois. | Finance |
Huron River Venture Partners LLC
Huron River Venture Partners LLC Investment ManagersFinance Huron River Venture Partners LLC (Huron River Venture) is a venture capital firm founded in 2010 by Ryan Waddington and Tim Streit. The firm is headquartered in Ann Arbor, Michigan. | Finance |
Hyde Park Venture Partners Management LLC
Hyde Park Venture Partners Management LLC Investment ManagersFinance Hyde Park Venture Partners Management LLC (Hyde Park Venture Partners) is a venture capital firm founded in 2011 by Guy Turner. The firm is headquartered in Chicago, Illinois. | Finance |
Tempus Labs, Inc.
Tempus Labs, Inc. Information Technology ServicesTechnology Services Tempus Labs, Inc. enagegs in the development of a platform that analyzes clinical and molecular data points focusing on cancer research. It connects physicians treatment options and relevant insights for patients based on their unique molecular profile and analytics and machine-learning algorithms. The firm offers genomic sequencing, clinical data structuring, image recognition, biological modeling, and time trial program. The company was founded by Bradley A. Keywell and Eric P. Lefkofsky in 2015 and is headquartered in Chicago, IL. | Technology Services |
Rain Oncology, Inc.
 Rain Oncology, Inc. BiotechnologyHealth Technology Rain Oncology, Inc. is a clinical-stage precision oncology company, which focuses on developing and implement the precision oncology therapies for patients suffering from cancer. The company was founded by Avanish Vellanki and Robert Doebele in April 2017 and is headquartered in Newark, CA. | Health Technology |
Pathos AI, Inc.
Pathos AI, Inc. BiotechnologyHealth Technology The American company was founded by Ryan Fukushima and Eric Paul Lefkofsky, with Ryan Fukushima serving as the CEO since incorporation. Pathos AI leverages the power of AI technologies, multimodal real-world data, and patient-derived biological models to bring precision medicines to market through partnerships with biopharmaceutical companies. The company is focused on re-engineering drug development with the power of advanced AI technologies and has built a proprietary platform and operating model called Pathos to gain crucial insights and act on them at scale. | Health Technology |
